Edema News and Research

RSS

Edema means swelling caused by fluid in your body's tissues. It usually occurs in the feet, ankles and legs, but it can involve your entire body.

Radiance FN/Radiesse injectable implant material appears effective and well tolerated by patients undergoing facial soft tissue augmentation

An article in the July/August issue of the Archives of Facial Plastic Surgery reports that the use of Radiance FN/Radiesse injectable implant material appears effective and well tolerated by patients undergoing facial soft tissue augmentation, and patient satisfaction with treatment is high.

20 Jul 2004

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

An article in the July issue of the Archives of Neurology reports that the drugs levodopa and pramipexole both appear to be reasonable options as initial therapy for Parkinson disease, but they are associated with different efficacy and adverse effects.

20 Jul 2004

3M granted FDA approval for cream to treat superficial basal cell carcinoma

3M announced today that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of nonmelanoma skin cancer.

16 Jul 2004

New leads for the discovery of anthrax antitoxins that could be used in conjunction with antibiotics to treat late-stage anthrax

A team of researchers led by The Burnham Institute’s Robert C. Liddington has determined the crystal structure of the binding complex between anthrax toxin and one of its host receptors.

8 Jul 2004

Rabies infections in organ donor and transplant recipients

On June 30, 2004, CDC confirmed diagnoses of rabies in three recipients of transplanted organs and in their common donor, who was found subsequently to have serologic evidence of rabies infection.

2 Jul 2004

Investigational drug Abraxane is active and well tolerated in women with metastatic breast cancer

Investigational drug Abraxane™ (albumin nanoparticle paclitaxel), administered weekly without steroid premedication, is active and well tolerated in women with metastatic breast cancer whose disease had progressed while they were treated with paclitaxel (Taxol®) and/or docetaxel (Taxotere®).

15 Jun 2004

Vasamed announces patent for a novel pulse oximeter

Vasamed, developer and supplier of hemodynamic monitoring products, announced that the U.S. Patent and Trademark Office granted it a method patent for a novel pulse oximeter that incorporates signals from a laser Doppler velocimeter (LDV) and an impedance cardiograph (ICG) to accomplish the measurement of oxygen saturation.

25 May 2004

Oxygen delivered through the nose may improve poor vision caused by diabetic macular edema

In a study of five diabetic patients with persistent macular edema, breathing supplemental oxygen for three months reduced fluid buildup and swelling in the macula and, in some cases, improved visual acuity. Researchers think the therapy could be used in conjunction with laser treatments that also improve oxygenation in the retina to provide long-term stability in these patients.

20 May 2004

Study has important implications for African Americans who suffer from high blood pressure

A new study has important implications for the millions of African Americans who suffer from high blood pressure. The study, AADVANCE, shows Diovan HCT(R) (valsartan and hydrochlorothiazide) lowers blood pressure in African Americans to aggressive recommended target blood pressure goals as effectively as amlodipine.

20 May 2004

Damaged metal halide lamps can cause sunburn

Ever think you could get a nasty sunburn — severe enough to peel — by attending an indoor event? Seems improbable, but it can happen. And it has — three times recently in Middle Tennessee.

19 May 2004

Oxygen delivered through the nose may improve poor vision caused by diabetic macular edema

Oxygen delivered through the nose may improve poor vision caused by diabetic macular edema, fluid buildup in the part of the eye responsible for central vision, according to a pilot study by scientists at Johns Hopkins and the National Eye Institute.

18 May 2004

Vocal surgery is now available to maintain performance level of the singing voice

Tissue in the vocal cords and the female reproductive system react similarly to the hormonal changes present during a woman’s menstrual cycle. In some women, the change in vocal cord tissue is pronounced, resulting in what researchers call “premenstrual voice syndrome” (PMVS).

29 Apr 2004

Serious allergic reactions in cancer patients require expert intervention

Studies show that up to 35 percent of cancer patients are at risk for an allergic reaction to their cancer therapy. Yet, the same drug causing the reaction could be the drug that best helps to control the disease.

28 Apr 2004

$11 million for lung injury research

Northwestern University has received an $11 million Program Project Grant (PPG) from the National Institutes of Health to define the mechanisms that cause changes in the alveolar epithelium during lung injury.

27 Apr 2004

FDA approves new breakthrough Parkinson's drug

FDA has approved Apokyn (apomorphine) as an injectable drug for treating Parkinson's patients during episodes of "hypomobility," so-called "off periods" in which the patient becomes immobile or unable to perform activities of daily living.

21 Apr 2004

Risk Assessment of Diabetic Retiopathy Improved by Screening Methods

Eli Lilly and Company as part of a continued commitment to innovation in the area of diabetes, announced today the creation of a strategic relationship with EyeTel Imaging, Inc. to improve screening and detection of diabetic retinopathy, one of the potentially devastating diabetic microvascular complications. The agreement, which expands the relationship between the two companies, will provide EyeTel with on-going operational support from Lilly, allowing EyeTel to provide primary care physicians access to state-of-the-art patient risk assessment tools and education programs.

23 Mar 2004

New treatment for heart attacks

A team led by scientists at The Scripps Research Institute has developed a potential new treatment for heart attacks. The therapy inhibits fluid leakage from cardiac blood vessels following a heart attack and thereby significantly prevents long-term heart damage and improves survival.

22 Mar 2004

Edema News and Research

Further Reading

Radiance FN/Radiesse injectable implant material appears effective and well tolerated by patients undergoing facial soft tissue augmentation

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

3M granted FDA approval for cream to treat superficial basal cell carcinoma

New leads for the discovery of anthrax antitoxins that could be used in conjunction with antibiotics to treat late-stage anthrax

Rabies infections in organ donor and transplant recipients

Investigational drug Abraxane is active and well tolerated in women with metastatic breast cancer

Vasamed announces patent for a novel pulse oximeter

Oxygen delivered through the nose may improve poor vision caused by diabetic macular edema

Study has important implications for African Americans who suffer from high blood pressure

Damaged metal halide lamps can cause sunburn

Oxygen delivered through the nose may improve poor vision caused by diabetic macular edema

Vocal surgery is now available to maintain performance level of the singing voice

Serious allergic reactions in cancer patients require expert intervention

$11 million for lung injury research

FDA approves new breakthrough Parkinson's drug

Risk Assessment of Diabetic Retiopathy Improved by Screening Methods

New treatment for heart attacks

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News